Bar-Or A - Search Results

1

The Identity of Human Tissue-Emigrant CD8⁺ T Cells.

Buggert M, Vella LA, Nguyen S, Wu VH, Chen Z, Sekine T, Perez-Potti A, Maldini CR, Manne S, Darko S, Ransier A, Kuri-Cervantes L, Japp AS, Brody IB, Ivarsson MA, Gorin JB, Rivera-Ballesteros O, Hertwig L, Antel JP, Johnson ME, Okoye A, Picker L, Vahedi G, Sparrelid E, Llewellyn-Lacey S, Gostick E, Sandberg JK, Björkström N, Bar-Or A, Dori Y, Naji A, Canaday DH, Laufer TM, Wells AD, Price DA, Frank I, Douek DC, Wherry EJ, Itkin MG, Betts MR. Buggert M, et al. Cell. 2020 Dec 23;183(7):1946-1961.e15. doi: 10.1016/j.cell.2020.11.019. Epub 2020 Dec 10. Cell. 2020. PMID: 33306960 Free PMC article.

2

Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes.

Williams K, Bar-Or A, Ulvestad E, Olivier A, Antel JP, Yong VW. Williams K, et al. J Neuropathol Exp Neurol. 1992 Sep;51(5):538-49. doi: 10.1097/00005072-199209000-00009. J Neuropathol Exp Neurol. 1992. PMID: 1517774

3

Persistence of immune responses to altered and native myelin antigens in patients with multiple sclerosis treated with altered peptide ligand.

Kim HJ, Antel JP, Duquette P, Alleva DG, Conlon PJ, Bar-Or A. Kim HJ, et al. Clin Immunol. 2002 Aug;104(2):105-14. doi: 10.1006/clim.2002.5258. Clin Immunol. 2002. PMID: 12165271 Clinical Trial.

4

Differential effects of Th1 and Th2 lymphocyte supernatants on human microglia.

Séguin R, Biernacki K, Prat A, Wosik K, Kim HJ, Blain M, McCrea E, Bar-Or A, Antel JP. Séguin R, et al. Glia. 2003 Apr 1;42(1):36-45. doi: 10.1002/glia.10201. Glia. 2003. PMID: 12594735

5

Determinants of human B cell migration across brain endothelial cells.

Alter A, Duddy M, Hebert S, Biernacki K, Prat A, Antel JP, Yong VW, Nuttall RK, Pennington CJ, Edwards DR, Bar-Or A. Alter A, et al. J Immunol. 2003 May 1;170(9):4497-505. doi: 10.4049/jimmunol.170.9.4497. J Immunol. 2003. PMID: 12707326

6

Do myelin-directed antibodies predict multiple sclerosis?

Antel JP, Bar-Or A. Antel JP, et al. N Engl J Med. 2003 Jul 10;349(2):107-9. doi: 10.1056/NEJMp030098. N Engl J Med. 2003. PMID: 12853581 No abstract available.

7

Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patients.

Kim HJ, Biernacki K, Prat A, Antel JP, Bar-Or A. Kim HJ, et al. Clin Immunol. 2004 Apr;111(1):38-46. doi: 10.1016/j.clim.2004.01.004. Clin Immunol. 2004. PMID: 15093550

8

Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis.

Kim HJ, Ifergan I, Antel JP, Seguin R, Duddy M, Lapierre Y, Jalili F, Bar-Or A. Kim HJ, et al. J Immunol. 2004 Jun 1;172(11):7144-53. doi: 10.4049/jimmunol.172.11.7144. J Immunol. 2004. PMID: 15153538

9

Microglia and multiple sclerosis.

Jack C, Ruffini F, Bar-Or A, Antel JP. Jack C, et al. J Neurosci Res. 2005 Aug 1;81(3):363-73. doi: 10.1002/jnr.20482. J Neurosci Res. 2005. PMID: 15948188 Review.

10

Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate.

Arbour N, Rastikerdar E, McCrea E, Lapierre Y, Dörr J, Bar-Or A, Antel JP. Arbour N, et al. Mult Scler. 2005 Dec;11(6):652-7. doi: 10.1191/1352458505ms1222oa. Mult Scler. 2005. PMID: 16320724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

395 results

Search Page